Objective To measure the coefficient of variation of the harmonic magnitude (HCV) of the radial arterial pulse before death of cancer patients.
Introduction
As Glass stated, 'Physiological rhythms are central to life. Disruption of rhythmic processes beyond normal bounds or emergence of abnormal rhythms is associated with disease' [1] . Indeed, death is the termination of all physiological rhythms. Is there a biological rhythm that reflects most diseases and is associated with the dying process? It must be the fundamental component of the physiological rhythms.
In both philosophy and medicine, death is a major issue. The questions 'Will this patient die?' and 'When will this patient die?' are some of the most difficult questions that doctors face. Sudden death is even more troublesome. However, these unavoidable problems and risks must be seriously addressed in intensive care units, ambulances, emergency wards, anaesthetized patients undergoing surgery, and patients in hospices who have end-stage cancer. Because the answers to these questions affect the course of treatment as well as the feelings of the patients' families, there are broad implications for them in medical economics and society [2, 3] .
Nevertheless, the accurate forecasting of death is not an easy matter, and many predictive systems have been formulated. These include the assessment of patients' condition near death [3] [4] [5] [6] , Simplified Acute Physiology (SAPS) scores [2] , Mortality Probability Model (MPM) scores [2, 7] , Palliative Prognostic Index (PPI) scores [8] , Acute Physiology and Chronic Health Evaluation (APACHE) scores [9] , and even the use of neural networks to assist prediction [10] . Most of these predictive systems are qualitative, so there are differences in accuracy, limits due to technique, or variance due to ethnic differences [9, 11] . Thus, to establish a broad and accurate system to forecast death, an objective quantitative indicator is needed.
Blood pressure, heart rate, arterial oxygen concentration, body temperature, and breath rate are frequently used as physiological quantitative indicators of death. These vital signs cannot provide enough information, however, because they are usually kept within normal range by the intervention of treatment. Thus, the advanced analysis of these quantitative vital signs has become a new direction of research [12, 13] . Heart rate variability has been the most successful quantitative indicator so far [14, 15] . It has been extensively studied in cardiac and brain death [16] [17] [18] [19] . Research has been widely applied in clinical situations to evaluate prognosis and outcome [18] [19] [20] [21] [22] [23] . Some studies combined blood pressure with heart rate variability and obtained complements to diagnosis [17, 24] . However, there is little information on blood pressure variability during the dying process in cancer patients specifically [25] . Can decoding the fluctuations in physiological rhythms fully answer questions regarding the dying process?
The importance of information within arterial pulse waves has been recognized in clinical medicine for a long time [26] . Arterial pulse wave analysis has been used widely in clinical practice, such as in hypertension, cardiac failure, and aging [27] . Previously, we found that the coefficient of variation of the harmonic magnitude (HCV) of caudate arterial pulse was raised significantly during the dying process in rats [28] , and the HCV of arterial pulse increased before the fatal drop of blood pressure. We propose that HCV could be a good indicator to forecast the approach of death. This study was conducted on humans to confirm the proposal.
Methods
End-stage cancer patients admitted to the Hospice and Palliative Care Unit of National Taiwan University Hospital were recorded during the 2-week study. The experiments were conducted with the permission of patients or their family, and the responsible ethical committee has approved the experiments. Non-invasive pulse pressure of the radical artery was obtained once daily between 1500 and 1800 h by a pressure transducer (PSL-200GL; Kyowa Electronic Instrument Co. Ltd., Minato-ku, Tokyo, Japan). The device was fixed on the skin by scotch tape and an adjustable belt with a small button to give suitable pressure on the transducer. Our criterion of a good measurement was to seek the largest amplitude of the pulse [29] . As a control group, we also recorded 31 healthy subjects without obvious symptoms and 47 outpatient department (OPD) patients.
The output of the transducer was connected to an IBM PC for analysis via an A/D converter with sampling rate = 250 datapoints/s. The pulse spectrum was analysed with the Fourier transformation using T (period) = 1 pulse time [30] .
After Fourier transformation, we analysed the first six harmonic magnitudes [31] . Each measurement recorded 8 s and contained 4-15 whole pulses. The mean value of the magnitude and the standard deviation of each harmonic were calculated. The coefficient of variation equals the standard deviation divided by the mean.
We then compared the HCV of the first six components within each group [32] . We also used the coefficient of variation to analyse the stability of each harmonic component, taking 15% as the threshold. If the coefficient of variation of a harmonic component was higher than 15%, we regarded the harmonic component as having lost stability.
Results
During the study, we recorded the pulse pressure of 21 end-stage cancer patients. Among them, eight persons expired, five females and three males. The age and blood pressure of the healthy subjects, the OPD patients, and the end-stage cancer patients are summarized in Table 1 .
After Bonferroni t-tests were performed, we found that there were no significant differences in age, systolic blood pressure, and diastolic blood pressure between the healthy subjects and the OPD patients; however, the sixth HCV was significantly higher in the OPD patients (Bonferroni t-test, P < 0.05; Fig. 1 ). Between the OPD patients and the end-stage cancer patients, there were no significant differences in age, systolic blood pressure, and diastolic blood pressure; however, all the HCVs were significantly higher in the end-stage cancer patients than in the OPD patients (Bonferroni t-test, P < 0.05; Fig. 1 ). Comparing the data of the 13 living and the eight expired end-stage cancer patients, there were no significant differences in age, systolic blood pressure, and diastolic blood pressure; however, the first and second HCV values were significantly higher in the end-stage cancer patients that expired (Bonferroni t-test, P < 0.05; Fig. 1 ).
Looking more closely at the last 2 days of those end-stage cancer patients that expired, we found that the first to fourth HCVs increased significantly on the last day as compared with those recorded one day before (paired t-test, P < 0.05; Fig. 2 ), even though there were no significant changes in the systolic and diastolic blood pressures. When we analysed the stability of the harmonic components, we found that in the control healthy subjects the HCVs were all below 5%. The HCVs of the OPD patients were all below 8%. In the cancer patients, only the first and the second HCVs were less than 15%, while the third to sixth HCVs exceeded 40% (i.e., lost their stability). On the last day of those cancer patients that expired, even the first and second HCVs were higher than 15%; that is, all harmonic components lost stability on the day of expiration, reflecting the failure of the circulatory system during the dying process.
Discussion
During the study, only eight persons expired in the hospital. According to Taiwanese social customs, people don't want themselves or family members to die in the hospital. Some patients were taken home before death, and we could not record their pulses. One of the cancer patients expired in the hospital within 1 day of admission. We included this data in the Bonferroni t-test, but in the paired t-test it was excluded.
Similar to the dying process of rats, the HCVs increased during the dying process of the end-stage cancer patients. In our previous experiments with rats, the dying process was initiated by injecting fatal doses of anaesthesia and the data were recorded every minute. In this experiment, we chose patients in the Hospice and Palliative Care Unit because they experienced a natural course of death and received the least medical intervention. Despite the pulse of the cancer patients being recorded only once daily, similar results to the rat study confirmed that the HCVs could be used as a quantitative indicator reflecting physiological changes during the dying process. This result is also consistent with the statement of Singh et al., 'the (single or 1-min or even 24-h) measurement of heart rate and blood pressure can be taken to ascertain whether a patient is dead or alive [24] '.
In clinical practice, systolic and diastolic blood pressures are important physiological indicators, and a dramatic drop in blood pressure is viewed as an important danger sign. However, due to treatment interventions, these indicators are usually kept within normal range [11] . The systolic and diastolic blood pressures on the last day of the patients were not significantly different from that of the second to last day, but we found that the mean systolic blood pressure was higher on the last day (Table 1) , an example of treatment keeping the blood pressure within normal range. In addition, only two of the patients that expired during our study had systolic blood pressure below 90 mmHg and diastolic blood pressure below 60 mmHg on the last day when we recorded the data; the other six patients that expired had blood pressures that were within normal range. The recorded HCVs, however, reflected the dying process by losing stability in all harmonic components. Although one study has shown that the pulse rate variability is not a surrogate for heart rate variability [33] , HCVs might reveal more cardiovascular information in dying patients.
Furthermore, when comparing all groups, the HCVs of the expired patients increased gradually first in the Coefficient of variation of harmonic components in the healthy subjects (n = 31), outpatient department (OPD) patients (n = 47), the living end-stage cancer patients (n = 13), and the expired end-stage cancer patients (n = 8). Values are means ± SE. Black bars represent healthy subjects, grey bars represent OPD patients, dark grey bars represent the living end-stage cancer patients, and light grey bars represent the expired end-stage cancer patients. n, number of subjects. Between symbols such as * and P < 0.05 versus healthy subjects. F and P < 0.05 versus OPD patients. & and P < 0.05 versus the living endstage cancer patients. high-frequency components and then in the lowfrequency components. We conclude that the HCVs reflect the dying process in a quantitative way and clearly indicate the severity of illness for both humans and rats. It is possible that beat-to-beat fluctuations in the Fourier components of the cardiovascular rhythm could provide us with a measure of the body's health.
